Brief: Oramed - Oravax Gearing Up To Begin Clinical Trials For Oral Covid-19 Vaccine, First In Israel, Then In Additional Clinical Sites Internationally
21/07/2021 13:28
July 21 (Reuters) - Oramed Pharmaceuticals Inc ORMP.O :
* ORAMED - ORAVAX GEARING UP TO BEGIN CLINICAL TRIALS FOR
ORAL
COVID-19 VACCINE, FIRST IN ISRAEL, THEN IN ADDITIONAL CLINICAL
SITES INTERNATIONALLY
Source text for Eikon: ID:nPn6v8zc8a
Further company coverage: ORMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oramed Pharmaceuticals
See all newsBrief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
Brief: Oramed And Lifeward Announce Strategic Transaction
Brief: Oramed Receives $18 Million Payment From Scilex Holdings
Brief: Oramed Reports Fiscal Third Quarter 2025 Financial Results